Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Publishing timestamp: 2024-05-29 09:55:24
Summary
Ro launched a new tracker to help patients find GLP-1 weight loss and diabetes drugs amid shortages in the U.S. The tool aims to provide transparent and accessible supply information for everyone, regardless of enrollment in Ro's programs. The tracker allows users to report availability or shortages at specific pharmacies and receive alerts when drugs become available. The goal is to help patients and providers navigate the current shortages and inform the FDA in real-time.
Sentiment: MIXED
Keywords: novo nordisk a/s, business, breaking news, pharmaceuticals, biotech and pharmaceuticals, eli lilly and co, biotechnology, business news, health care industry,